Cannabigerovarin Explained

Cannabigerovarin (CBGV), the propyl homolog of cannabigerol (CBG), is a cannabinoid present in Cannabis.[1] [2] [3] [4] There is no observation related to the psychoactive or psychotropic effects of CBGV when consumed or inhaled.[5] The possible benefits of cannabigerovarin in human bodies are painkilling and anti-inflammatory properties to treat conditions like fibromyalgia and arthritis, the treatment and improvement of the dry-skin syndrome, cancer treatment by reducing the growth of cancer cells in patients who have leukemia.[6] [7] [8] [9] According to the pain-relieving effects of this natural cannabinoid, it can be helpful to treat patients who were undergoing drug exposure like chemotherapy or radiation therapy.[10] In addition, cannabigerol metabolism increases and has a better absorption from the body when paired with cannabigerovarin.[11]

Notes and References

  1. Tolomeo. Francesco. Russo. Fabiana. Vandelli. Maria Angela. Biagini. Giuseppe. Capriotti. Anna Laura. Laganà. Aldo. Carbone. Luigi. Gigli. Giuseppe. Cannazza. Giuseppe. Citti. Cinzia. September 2021. HPLC–UV–HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp. Journal of Pharmaceutical and Biomedical Analysis. 203. 114215. 10.1016/j.jpba.2021.114215. 34153935. 0731-7085.
  2. Web site: What is Cannabigerovarin (CBGV)?. 2021-11-24. Marijuana Doctors Online Medical Card Directory. en.
  3. Hillig. Karl W.. Mahlberg. Paul G.. 2004. A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany. en. 91. 6. 966–975. 10.3732/ajb.91.6.966. 21653452. 32469533 . 1537-2197. free.
  4. de Meijer. E. P. M.. Hammond. K. M.. Micheler. M.. 2009-01-01. The inheritance of chemical phenotype in Cannabis sativa L. (III): variation in cannabichromene proportion. Euphytica. en. 165. 2. 293–311. 10.1007/s10681-008-9787-1. 24132168. 1573-5060.
  5. Oláh. Attila. Markovics. Arnold. Szabó-Papp. Judit. Szabó. Pálma Tímea. Stott. Colin. Zouboulis. Christos C.. Bíró. Tamás. September 2016. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Experimental Dermatology. en. 25. 9. 701–707. 10.1111/exd.13042. 27094344. 2437/243742. 39290296. free.
  6. Chakravarti. Bandana. Ravi. Janani. Ganju. Ramesh K.. 2014-07-17. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 5. 15. 5852–5872. 10.18632/oncotarget.2233. 25115386. 4171598. 1949-2553.
  7. Burstein. Sumner. April 2015. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorganic & Medicinal Chemistry. 23. 7. 1377–1385. 10.1016/j.bmc.2015.01.059. 25703248. 0968-0896.
  8. Grof. Christopher P. L.. 2018-05-24. Cannabis, from plant to pill. British Journal of Clinical Pharmacology. 84. 11. 2463–2467. 10.1111/bcp.13618. 29701252. 6177712. 0306-5251.
  9. Alsen. Mathilda. Sinclair. Catherine. Cooke. Peter. Ziadkhanpour. Kimia. Genden. Eric. van Gerwen. Maaike. 2021-01-19. Endocrine Disrupting Chemicals and Thyroid Cancer: An Overview. Toxics. 9. 1. 14. 10.3390/toxics9010014. 33477829. 7832870. 2305-6304. free.
  10. Web site: 2020-09-25. What is CBGV?. 2021-11-24. Botany Farms. en.
  11. de Meijer. E. P. M.. Hammond. K. M.. September 2005. The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants. Euphytica. en. 145. 1–2. 189–198. 10.1007/s10681-005-1164-8. 13496446. 0014-2336.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Cannabigerovarin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.